| 1 |
33592119 | Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group. | 2021 Jun |
1 |
| 2 |
32216001 | Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34+ cells under cytokine stimulation. | 2020 May |
1 |
| 3 |
32615949 | Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization. | 2020 Jul 2 |
1 |
| 4 |
29134688 | Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days. | 2018 Jun |
1 |
| 5 |
27677634 | Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro. | 2017 Jan |
2 |
| 6 |
27334858 | Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients. | 2016 |
1 |
| 7 |
24400988 | Chemomobilization with high-dose etoposide and G-CSF results in effective and safe stem cell collection in heavily pretreated lymphoma patients: report from a single institution study and review. | 2014 |
1 |
| 8 |
22019627 | Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: association with CD34(+) mobilization and with disease-free survival. | 2012 Jan |
1 |
| 9 |
21097707 | Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells. | 2011 Mar |
6 |
| 10 |
21135858 | Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. | 2011 Mar |
1 |
| 11 |
20642818 | Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy. | 2010 Jul 19 |
1 |
| 12 |
19587093 | Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. | 2009 Sep |
1 |
| 13 |
19899124 | Appropriate timing of G-CSF use after mobilization chemotherapy significantly increases the yield of CD34+ cells in autoPBSCT. | 2009 |
1 |
| 14 |
18510699 | Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. | 2008 Sep |
3 |
| 15 |
17618321 | Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies. | 2007 Sep |
1 |
| 16 |
17917963 | Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m(2) plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients. | 2007 Oct |
1 |
| 17 |
16503501 | Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. | 2006 Mar |
2 |
| 18 |
15528316 | Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion. | 2005 Mar 1 |
2 |
| 19 |
15815728 | Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. | 2005 Jun |
1 |
| 20 |
14730338 | Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma. | 2004 Mar |
1 |
| 21 |
14988151 | Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells. | 2004 Jun 15 |
1 |
| 22 |
12644023 | Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide. | 2003 Mar |
5 |
| 23 |
11372740 | Long-term survival and late-onset complications of cancer patients treated with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation. | 2001 Feb |
1 |
| 24 |
11594568 | Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival. | 2001 Sep |
1 |
| 25 |
10414907 | Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization. | 1999 Jun |
2 |
| 26 |
9516161 | Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. | 1998 Apr 1 |
1 |
| 27 |
9308634 | Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients. | 1997 Sep |
1 |
| 28 |
8794901 | Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells. | 1996 Sep |
1 |
| 29 |
7505211 | Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. | 1994 Jan |
1 |
| 30 |
7530135 | Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia. | 1994 Fall |
1 |